ESC & iPSC News Volume 18.45 | Nov 15 2023

    0
    17








    2023-11-15 | ESC 18.45


    ESC & iPSC News by STEMCELL Technologies
    Vol. 18.45 – 15 November, 2023
    TOP STORY

    Single-Cell, Whole-Embryo Phenotyping of Mammalian Developmental Disorders

    The authors established single-cell RNA sequencing of the whole embryo as a scalable platform for the systematic phenotyping of mouse genetic models.
    [Nature]

    Full Article
    Image of erythroblasts which were simply & efficiently generated from PSCs using the STEMdiff Erythroid Kit.
    PUBLICATIONSRanked by the impact factor of the journal

    Live Birth of Chimeric Monkey with High Contribution from Embryonic Stem Cells

    Investigators systematically tested various culture conditions for establishing monkey naive ESCs and optimized the procedures for chimeric embryo culture.
    [Cell]

    Full ArticleGraphical Abstract

    Functional Dissection of PRC1 Subunits RYBP and YAF2 during Neural Differentiation of Embryonic Stem Cells

    The authors showed that the expression of RYBP and YAF2 decreased and increased, respectively, during neural differentiation of ESCs. Rybp knockout impaired neural differentiation by activating Wnt signaling and derepressing nonneuroectoderm-associated genes.
    [Nature Communications]

    Full Article

    A Novel Perfusion Bioreactor Promotes the Expansion of Pluripotent Stem Cells in a 3D-Bioprinted Tissue Chamber

    Researchers designed a perfusion bioreactor for an hiPSC-laden, 3D-bioprinted chamber with the goal of proliferating the hiPSCs throughout the structure prior to differentiation to generate a thick tissue model.
    [Biofabrication]

    Full Article

    AT7867 Promotes Pancreatic Progenitor Differentiation of Human iPSCs

    Scientists performed pancreatic progenitor differentiation with and without AKT/P70 inhibitor AT7867 and characterized the resulting cells at protein and transcript level in vitro and in vivo upon transplantation into diabetic mice.
    [Stem Cell Reports]

    Full ArticleGraphical Abstract

    Induced Pluripotent Stem Cells Derived from Patients Carrying Mitochondrial Mutations Exhibit Altered Bioenergetics and Aberrant Differentiation Potential

    hiPSCs were generated from control BJ and four disease fibroblast lines using a cocktail of non-modified reprogramming and immune evasion mRNAs and microRNAs.
    [Current Stem Cell Research & Therapy]

    Full Article

    Comparison of Osteoclast Differentiation Protocols from Human Induced Pluripotent Stem Cells of Different Tissue Origins

    Researchers compared the osteoclastogenesis capacity of a peripheral blood mononuclear cell-derived iPSC line to a fibroblast-derived iPSC line in conjunction with either embryoid body-based or monolayer-based differentiation strategies.
    [Current Stem Cell Research & Therapy]

    Full Article

    The Application of Quantitative Telomerase Activity Measurement as an Important Indicator to Monitor the Cardiomyocyte Differentiation Process of Human Induced Pluripotent Stem Cells Under Defined Conditions

    Researchers used a quantitative method of cellular telomerase activity based on a quartz crystal microbalance device to monitor the dynamic changes in cellular telomerase activity in hiPSCs during myocardial differentiation under chemically defined conditions.
    [Biochemical And Biophysical Research Communications]

    Abstract

    Generation and Characterization of Induced Pluripotent Stem Cell Lines Derived from Skin Fibroblasts of Patients with Adrenoleukodystrophy

    The authors established two strains of iPSCs from skin fibroblasts of patients with childhood cerebral adrenoleukodystrophy and Addison’s disease, respectively. CytoTune™2.0 Sendai reprogramming kit was used.
    [Stem Cell Research]

    Full Article
    Request your free copy of the 'Growing Organoids from Stem Cells' Wallchart
    REVIEWS

    Induced Pluripotent Stem Cells-Based Disease Modeling, Drug Screening, Clinical Trials, and Reverse Translational Research for Amyotrophic Lateral Sclerosis

    For amyotrophic lateral sclerosis, a devastating neurodegenerative disease, several groups have identified candidate drugs, ezogabine, bosutinib, and ropinirole, using iPSCs-based drug discovery, and clinical trials using these drugs have been conducted, yielding interesting results.
    [Journal Of Neurochemistry]

    Full Article
    INDUSTRY AND POLICY NEWS

    This Hybrid Baby Monkey Is Made o’

    Scientists have created an infant ‘chimeric’ monkey by injecting a monkey embryo with stem cells from a genetically distinct donor embryo1. The resulting animal is the first live-born chimaeric primate to have a high proportion of cells originating from donor stem cells.
    [Nature]

    Press Release
    FEATURED EVENT

    Stem Cells and Regeneration

    January 22 – 25, 2024
    Santa Fe, New Mexico, United States

    > See All Events

    JOB OPPORTUNITIES

    Scientist Positions – Pharmaceutical Sciences

    China Pharmaceutical University – Nanjing, Jiangsu, China

    Postdoctoral Associate – Skin and ECM Biology

    Stony Brook University – Stony Brook, New York, United States

    Faculty Positions – Genetics and Genome Sciences

    Case Western Reserve University – Cleveland, Ohio, United States

    PhD Studentship – Development of Sensory Organs

    University of East Anglia – Norwich, England, United Kingdom

    Scientist – Pediatric Pathologist

    Indiana University School of Medicine- Indianapolis, Indiana, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2